Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes
Abstract Oncogenic membrane receptor tyrosine kinases such as MET and EGFR, or auto-active variants thereof, are important targets for cancer precision therapy. Targeted inhibition of these oncogenic receptors however invariably leads to resistance, resulting from acquisition of resistance-inducing...
Guardado en:
Autores principales: | Corina N. A. M. van den Heuvel, Arvid I. Das, Tessa de Bitter, Femke Simmer, Thomas Wurdinger, Miguel Angel Molina-Vila, William P. J. Leenders |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a96e3530439a41b7b9df6a5ba6233936 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
por: Sina Reckel, et al.
Publicado: (2017) -
Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells.
por: Florence Sancier, et al.
Publicado: (2011) -
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
por: Ian P. Winters, et al.
Publicado: (2017) -
Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
por: C. I. Edvard Smith, et al.
Publicado: (2021) -
Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Sachin Gupta, et al.
Publicado: (2008)